English | Español
Patient Daily | Dec 8, 2025

CDC advisory panel to review hepatitis B vaccine schedule under new chair Kirk Milhoan
Patient Daily | Dec 8, 2025

Imvax moves forward with FDA plans for glioblastoma drug after survival gain
Patient Daily | Dec 8, 2025

Biotechs move away from troubled Novo Nordisk plant amid FDA scrutiny
Patient Daily | Dec 8, 2025

Mount Sinai uses AI tool to improve early detection of congenital heart defects
Patient Daily | Dec 8, 2025

Nearly one million young children die yearly due to global child growth failure
Patient Daily | Dec 8, 2025

Penn Medicine researchers highlight advances in blood cancer research at ASH Annual Meeting
Patient Daily | Dec 8, 2025

Rice University develops erasable serum markers for improved tracking of brain activity
Patient Daily | Dec 8, 2025

Penn Medicine's Mobile CPR Project expands lifesaving training across Philadelphia

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor